Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lampl

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|August 10, 2000
Effectiveness and tolerability of zafirlukast for the treatment of asthma in childrenD S Pearlman, K L Lampl, P J Dowling, et al.
Frontiers in Cellular and Infection Microbiology|February 24, 2015
Milk- and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiomeAmanda L Thompson, Andrea Monteagudo-Mera, Maria B Cadenas, et al.
Journal of Safety Research|December 5, 2012
Development and evaluation of a Naïve Bayesian model for coding causation of workers' compensation claimsS J Bertke, A R Meyers, S J Wurzelbacher, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|October 8, 2017
Mesenchymal stem cells in peripheral blood of severely injured patientsR Wiegner, N-E Rudhart, E Barth, et al.
Annals of Allergy|April 1, 1989
Mortality versus improvement in severe chronic asthma: physiologic and psychologic factorsA Mascia, S Frank, A Berkman, et al.
Der Unfallchirurg|June 2, 2004
[Incidence of severe injuries. Results of a population-based analysis]U C Liener, U Rapp, L Lampl, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
JACC. Cardiovascular Imaging|April 19, 2024
Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy: Insight from the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
JACC. Cardiovascular Imaging|September 10, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM TrialMilind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.
Der Unfallchirurg|August 24, 2007
[Injury prevention as the physician's challenge]M Richter, G Lob, F Pühlhofer, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|August 10, 2000
Effectiveness and tolerability of zafirlukast for the treatment of asthma in childrenD S Pearlman, K L Lampl, P J Dowling, et al.
Frontiers in Cellular and Infection Microbiology|February 24, 2015
Milk- and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiomeAmanda L Thompson, Andrea Monteagudo-Mera, Maria B Cadenas, et al.
Journal of Safety Research|December 5, 2012
Development and evaluation of a Naïve Bayesian model for coding causation of workers' compensation claimsS J Bertke, A R Meyers, S J Wurzelbacher, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|October 8, 2017
Mesenchymal stem cells in peripheral blood of severely injured patientsR Wiegner, N-E Rudhart, E Barth, et al.
Annals of Allergy|April 1, 1989
Mortality versus improvement in severe chronic asthma: physiologic and psychologic factorsA Mascia, S Frank, A Berkman, et al.
Der Unfallchirurg|June 2, 2004
[Incidence of severe injuries. Results of a population-based analysis]U C Liener, U Rapp, L Lampl, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
JACC. Cardiovascular Imaging|April 19, 2024
Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy: Insight from the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
JACC. Cardiovascular Imaging|September 10, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM TrialMilind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.
Der Unfallchirurg|August 24, 2007
[Injury prevention as the physician's challenge]M Richter, G Lob, F Pühlhofer, et al.
Pageof 9